Affordable Access

EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx, Doxil) at a 6-week interval in patients with metastatic breast cancer. European Organization for Research and Treatment of Cancer.

Authors
Type
Published Article
Journal
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
Publication Date
Volume
13
Issue
6
Pages
910–918
Identifiers
PMID: 12123337
Source
Medline

Abstract

Statistics

Seen <100 times